1. Repositório Institucional - INCA
  2. Comunicação
  3. Revistas e Informes
  4. Informe INCA
  5. Informe INCA 2004
  6. Informe INCA 162
Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/15492
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2024-02-27T14:12:54Z-
dc.date.available2024-02-27T14:12:54Z-
dc.date.issued2004-01-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/15492-
dc.descriptionp. 2.: il. p&b.pt_BR
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.subjectFarmáciapt_BR
dc.subjectPharmacypt_BR
dc.subjectFarmaciapt_BR
dc.subjectAções Farmacológicaspt_BR
dc.subjectPharmacologic Actionspt_BR
dc.subjectAcciones Farmacológicaspt_BR
dc.titleFarmácia do HCI traça planos para 2004pt_BR
dc.title.alternativeInforme INCA 162pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 162

Files in This Item:
File Description SizeFormat 
Informe_INCA_162-2-farmácia-do-HCI.pdf625.84 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.